Reversing the Promise Doctrine An Important Step for Canadian Patent Law

July 7, 2017

 

Richard Owens writes that the Candian Supreme Court's decision in AstraZeneca v. Apotex, which overruled the invidious “promise doctrine," represents an important step forward in Canadian patent law, bringing it closer to international norms and helping to support the cause of innovation in technology, knowledge, and IP-based industries,